Dr. Demetriades is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1305 York Ave
11th floor
New York, NY 10021Phone+1 646-962-2020Fax+1 646-962-0604
Education & Training
- University of Miami/Jackson Health SystemFellowship, Bascom Palmer Eye Institute, 2009 - 2010
- Johns Hopkins UniversityResidency, Ophthalmology, 2006 - 2009
- New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 2005 - 2006
- Oxford University Medical SchoolClass of 2000
Certifications & Licensure
- CA State Medical License 2021 - 2025
- NY State Medical License 2010 - 2025
- FL State Medical License 2009 - 2011
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 13 citationsATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.Ailing Sui, Yisheng Zhong, Anna M. Demetriades, Jikui Shen, Ting Su
Medical Science Monitor. 2018-08-22 - 38 citationsInhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced i...Ailing Sui, Xiuping Chen, Jikui Shen, Anna M. Demetriades, Yiyun Yao
Cell Death & Disease. 2020-10-22 - 21 citationsInhibiting NF-κB Signaling Activation Reduces Retinal Neovascularization by Promoting a Polarization Shift in MacrophagesAiling Sui, Xiuping Chen, Anna M. Demetriades, Jikui Shen, Yujuan Cai
Investigative Ophthalmology & Visual Science. 2020-06-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: